A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
出版年份 2021 全文链接
标题
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
作者
关键词
-
出版物
Nature Communications
Volume 12, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-28
DOI
10.1038/s41467-021-20912-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
- (2019) Mercedes Segovia et al. CANCER CELL
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
- (2019) Jonathan Benzaquen et al. Biomedical Journal
- Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease
- (2019) Germain Homerin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tissue-Resident Memory T Cells in Cancer Immunosurveillance
- (2019) Simone L. Park et al. TRENDS IN IMMUNOLOGY
- Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
- (2019) Xian-Yang Li et al. Cancer Discovery
- Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation
- (2018) Francesco Di Virgilio et al. Frontiers in Pharmacology
- P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
- (2018) Chris N. J. Young et al. Frontiers in Chemistry
- Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance
- (2018) Zachary Schrank et al. Cancers
- ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
- (2018) SM Gilbert et al. ONCOGENE
- Ginsenosides Act As Positive Modulators of P2X4 Receptors
- (2018) Kshitija Dhuna et al. MOLECULAR PHARMACOLOGY
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- P2X7 receptor antagonists: a patent review (2010–2015)
- (2016) Jin-Hee Park et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer
- (2015) P. Hofman et al. CANCER RESEARCH
- Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies
- (2015) Alexander M.M. Eggermont et al. SEMINARS IN ONCOLOGY
- Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma
- (2015) Michael A. Postow et al. Journal for ImmunoTherapy of Cancer
- Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
- (2014) E. Adinolfi et al. CANCER RESEARCH
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Multiple cells-of-origin of mutant K-Ras–induced mouse lung adenocarcinoma
- (2014) Kate D. Sutherland et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural compounds with P2X7 receptor-modulating properties
- (2013) Wolfgang Fischer et al. Purinergic Signalling
- Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages
- (2012) Ayumi Kawano et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration
- (2010) Annabelle Cesaro et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Extracellular NAD+shapes the Foxp3+regulatory T cell compartment through the ART2–P2X7 pathway
- (2010) Sandra Hubert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients
- (2009) Sandra Beijer et al. ANTI-CANCER DRUGS
- Atypical Protein Kinase C Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
- (2009) R. P. Regala et al. CANCER RESEARCH
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
- (2009) Michel DuPage et al. Nature Protocols
- Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
- (2008) Patrizia Pellegatti et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now